Cost burden and resource utilization in patients with chronic rhinosinusitis and nasal polyps-Reference-Cited by-同舟云学术

Cost burden and resource utilization in patients with chronic rhinosinusitis and nasal polyps

Published:2019-02-05 Issue:9 Volume:129 Page:1969-1975
ISSN:0023-852X
Container-title:The Laryngoscope
language:en
Short-container-title:The Laryngoscope

Author:

Bhattacharyya Neil¹^ORCID,Villeneuve Sara²,Joish Vijay N.³,Amand Caroline⁴,Mannent Leda⁴,Amin Nikhil³,Rowe Paul³,Maroni Jaman³,Eckert Laurent⁴,Yang Tony⁵,Khan Asif⁴

Affiliation:

1. Brigham and Women's Hospital and Harvard Medical School Boston Massachusetts U.S.A.

2. IVIDATA Stats Levallois‐Perret France

3. Regeneron Pharmaceuticals, Inc. Tarrytown New York U.S.A.

4. Sanofi Chilly‐Mazarin France

5. Sanofi US Bridgewater New Jersey U.S.A

Funder

Regeneron Pharmaceuticals

Sanofi

Publisher

Wiley

Subject

Otorhinolaryngology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/lary.27852

Reference26 articles.

1. Chronic rhinosinusitis management beyond intranasal steroids and saline solution irrigations

2. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists

3. A Review of Classification Schemes for Chronic Rhinosinusitis with Nasal Polyposis Endotypes

4. Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis

5. Incremental Health Care Utilization and Expenditures for Chronic Rhinosinusitis in the United States

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Overweight on Response to Dupilumab Treatment in Chronic Rhinosinusitis with Nasal Polyps;Nutrients;2024-09-04

2. Nasal brushing molecular endotyping distinguishes patients with chronic rhinosinusitis with nasal polyps with better response to dupilumab;Journal of Allergy and Clinical Immunology;2024-09

3. Dupilumab response onset, maintenance, and durability in patients with severe CRSwNP;Journal of Allergy and Clinical Immunology;2024-08

4. Dupilumab improved objective and patient-reported outcomes in patients with chronic rhinosinusitis with nasal polyps and complete nasal obstruction;Exploration of Asthma & Allergy;2024-07-30

5. The Role of Allergy in Central Compartment Atopic Disease;Current Treatment Options in Allergy;2024-06-28